Lowe Brockenbrough & CO Inc Abbott Laboratories Transaction History

Lowe Brockenbrough & CO Inc

  • $1.5 Billion
  • Q1 2025

A detailed history of Lowe Brockenbrough & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Lowe Brockenbrough & CO Inc holds 41,913 shares of ABT stock, worth $5.6 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
41,913
Previous 42,794 2.06%
Holding current value
$5.6 Million
Previous $4.84 Million 14.86%
% of portfolio
0.37%
Previous 0.31%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$111.1 - $140.22 $97,879 - $123,533
-881 Reduced 2.06%
41,913 $5.56 Million
Q4 2024

Feb 11, 2025
SELL
$111.93 - $119.39 $91,782 - $97,899
-820 Reduced 1.88%
42,794 $4.84 Million
Q3 2024

Oct 28, 2024
BUY
$100.07 - $118.13 $161,713 - $190,898
1,616 Added 3.85%
43,614 $4.97 Million
Q2 2024

Aug 12, 2024
SELL
$100.73 - $112.44 $126,516 - $141,224
-1,256 Reduced 2.9%
41,998 $4.36 Million
Q1 2024

May 15, 2024
SELL
$109.52 - $120.96 $408,509 - $451,180
-3,730 Reduced 7.94%
43,254 $4.92 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $18,579 - $22,742
-206 Reduced 0.44%
46,984 $5.17 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $466,759 - $560,033
-4,886 Reduced 9.38%
47,190 $4.57 Million
Q2 2023

Aug 10, 2023
SELL
$100.78 - $112.29 $34,970 - $38,964
-347 Reduced 0.66%
52,076 $5.68 Million
Q1 2023

May 12, 2023
BUY
$96.86 - $114.01 $208,442 - $245,349
2,152 Added 4.28%
52,423 $5.31 Million
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $190,215 - $223,151
-2,001 Reduced 3.83%
50,271 $5.52 Million
Q3 2022

Nov 01, 2022
SELL
$96.76 - $112.03 $33,962 - $39,322
-351 Reduced 0.67%
52,272 $5.06 Million
Q2 2022

Jul 27, 2022
SELL
$102.07 - $123.37 $266,708 - $322,365
-2,613 Reduced 4.73%
52,623 $5.72 Million
Q1 2022

May 04, 2022
SELL
$114.02 - $139.04 $318,913 - $388,894
-2,797 Reduced 4.82%
55,236 $6.54 Million
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $97,853 - $119,816
-847 Reduced 1.44%
58,033 $8.17 Million
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $115,610 - $127,898
991 Added 1.71%
58,880 $6.96 Million
Q2 2021

Aug 13, 2021
BUY
$105.79 - $124.53 $508,215 - $598,242
4,804 Added 9.05%
57,889 $6.71 Million
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $40,161 - $47,316
-369 Reduced 0.69%
53,085 $6.36 Million
Q4 2020

Feb 04, 2021
SELL
$105.0 - $114.42 $27,195 - $29,634
-259 Reduced 0.48%
53,454 $5.85 Million
Q3 2020

Oct 26, 2020
SELL
$91.64 - $111.29 $364,635 - $442,822
-3,979 Reduced 6.9%
53,713 $5.85 Million
Q2 2020

Aug 13, 2020
SELL
$76.57 - $98.0 $3,062 - $3,920
-40 Reduced 0.07%
57,692 $5.28 Million
Q1 2020

May 21, 2020
SELL
$62.82 - $91.86 $199,076 - $291,104
-3,169 Reduced 5.2%
57,732 $4.56 Million
Q4 2019

Jan 31, 2020
BUY
$78.51 - $87.4 $87,931 - $97,888
1,120 Added 1.87%
60,901 $5.29 Million
Q3 2019

Nov 21, 2019
SELL
$81.84 - $88.74 $27,170 - $29,461
-332 Reduced 0.55%
59,781 $5 Million
Q2 2019

Aug 12, 2019
SELL
$72.88 - $85.0 $137,743 - $160,650
-1,890 Reduced 3.05%
60,113 $5.06 Million
Q1 2019

May 21, 2019
BUY
$66.22 - $80.06 $100,257 - $121,210
1,514 Added 2.5%
62,003 $4.96 Million
Q4 2018

Feb 15, 2019
SELL
$65.56 - $74.27 $32,976 - $37,357
-503 Reduced 0.82%
60,489 $4.38 Million
Q3 2018

Nov 15, 2018
SELL
$60.81 - $73.36 $72,789 - $87,811
-1,197 Reduced 1.92%
60,992 $4.47 Million
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $12,780 - $14,105
-222 Reduced 0.36%
62,189 $3.79 Million
Q1 2018

Apr 30, 2018
BUY
$56.27 - $63.62 $31,061 - $35,118
552 Added 0.89%
62,411 $3.74 Million
Q4 2017

Jan 30, 2018
BUY
$53.68 - $57.47 $2,147 - $2,298
40 Added 0.06%
61,859 $3.53 Million
Q3 2017

Nov 07, 2017
BUY
$48.06 - $53.64 $2.97 Million - $3.32 Million
61,819
61,819 $3.3 Million

Others Institutions Holding ABT

# of Institutions
3,541
Shares Held
1.38B
Call Options Held
9.75M
Put Options Held
8.87M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $234B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lowe Brockenbrough & CO Inc Portfolio

Follow Lowe Brockenbrough & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Brockenbrough & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Brockenbrough & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email